SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-10-278879
Filing Date
2010-12-13
Accepted
2010-12-13 08:37:17
Documents
5
Group Members
GC MERGER CORP.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 8 TO SCHEDULE TO dsctota.htm SC TO-T/A 36940
2 PRESS RELEASE dex99a5i.htm EX-99.(A)(5)(I) 5920
4 GRAPHIC g127268g62u57.jpg GRAPHIC 28984
5 GRAPHIC g127268g90r08.jpg GRAPHIC 49479
6 filename6.htm CORRESP 10779
  Complete submission text file 0001193125-10-278879.txt   163843
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Subject) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-37205 | Film No.: 101246753
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 174 AVENUE DE FRANCE PARIS I0 75013
Business Address 174 AVENUE DE FRANCE PARIS I0 75013 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations